Lv62
2270 积分 2022-06-16 加入
678 Updated safety and efficacy of toripalimab combined with cetuximab in platinum-refractory recurrent or metastatic head and neck squamous cell carcinoma (R/M-HNSCC): a phase Ib/II clinical trial
5小时前
已完结
Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial
8天前
已完结
Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials
14天前
已完结
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
15天前
已完结
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma
15天前
已完结
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
22天前
已完结
Review of Current and Future Medical Treatments in Head and Neck Squamous Cell Carcinoma
23天前
已关闭
Head and Neck Cancer
23天前
已完结
The role and regulation of integrins in cell migration and invasion
1个月前
已完结
Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma
1个月前
已关闭
皖公网安备34019202002308
